Americans may not understand survival nuances in cancer brand commercials, FDA research finds
TV viewers in the US may be getting confused by cancer drug commercials.
A recently published FDA study found that after watching commercials the agency created for fictitious oncology drugs, some people drew incorrect conclusions about living longer, reinforcing the FDA’s hypothesis about the need for disclosures.
The survey participants could explain, when asked open-ended questions, what was meant by cancer drug response rates or progression-free survival. But after watching the TV ads, when asked questions about whether patients could live longer, some drew the wrong conclusions.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters